Condition: Nephrotic Syndrome in Children · Telitacicept · Sponsor: The Children's Hospital of Zhejiang University School of Medicine
The main objective is to evaluate the effectiveness of telitacicept in pediatric patients with frequently relapsing or steroid dependent nephrotic syndrome within the 52-week follow-up.
This description comes directly from the study's public registry record.
Jianhua Mao, MD · 86057186670015 · maojh88@zju.edu.cn
Chunyue Feng · springmoonfeng@163.com
Always discuss trial participation with your own doctor first.
| Children's Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06125405